CN114644621B - 治疗新冠肺炎口服药物s-217622的制备方法 - Google Patents
治疗新冠肺炎口服药物s-217622的制备方法 Download PDFInfo
- Publication number
- CN114644621B CN114644621B CN202210431649.3A CN202210431649A CN114644621B CN 114644621 B CN114644621 B CN 114644621B CN 202210431649 A CN202210431649 A CN 202210431649A CN 114644621 B CN114644621 B CN 114644621B
- Authority
- CN
- China
- Prior art keywords
- methyl
- dione
- triazine
- triazole
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210431649.3A CN114644621B (zh) | 2022-04-22 | 2022-04-22 | 治疗新冠肺炎口服药物s-217622的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210431649.3A CN114644621B (zh) | 2022-04-22 | 2022-04-22 | 治疗新冠肺炎口服药物s-217622的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN114644621A CN114644621A (zh) | 2022-06-21 |
CN114644621B true CN114644621B (zh) | 2023-08-22 |
Family
ID=81996796
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210431649.3A Active CN114644621B (zh) | 2022-04-22 | 2022-04-22 | 治疗新冠肺炎口服药物s-217622的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114644621B (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115650959B (zh) * | 2022-05-20 | 2023-10-20 | 南京济群医药科技股份有限公司 | 化合物的制备方法或纯化方法 |
CN115626917B (zh) * | 2022-06-22 | 2023-03-07 | 北京远大九和药业有限公司 | 化合物的晶型及其组合物和用途 |
CN115141184A (zh) * | 2022-06-23 | 2022-10-04 | 杭州国瑞生物科技有限公司 | 一种恩赛特韦的制备方法 |
CN115260166B (zh) * | 2022-07-13 | 2023-12-19 | 山东轩硕医药科技有限公司 | 一种高效合成s-217622的化学方法 |
CN114933594A (zh) * | 2022-07-20 | 2022-08-23 | 北京科翔中升医药科技有限公司 | 一种氟代三嗪类化合物、药物组合物及用途 |
CN116514786A (zh) * | 2023-06-26 | 2023-08-01 | 北京科翔中升医药科技有限公司 | 一种氘代吲唑三嗪类化合物的制备方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022035911A2 (en) * | 2020-08-11 | 2022-02-17 | Tutela Pharmaceuticals, Inc. | Methods of treating coronavirus infections by co-administering an fkbp ligand and an antiviral agent |
-
2022
- 2022-04-22 CN CN202210431649.3A patent/CN114644621B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022035911A2 (en) * | 2020-08-11 | 2022-02-17 | Tutela Pharmaceuticals, Inc. | Methods of treating coronavirus infections by co-administering an fkbp ligand and an antiviral agent |
Non-Patent Citations (1)
Title |
---|
Discovery of S‑ 217622, a Noncovalent Oral SARS-CoV ‑ 2 3CL Protease Inhibitor Clinical Candidate for Treating COVID-19;Yuto Unoh等;《J. Med. Chem.》;6499−6512 * |
Also Published As
Publication number | Publication date |
---|---|
CN114644621A (zh) | 2022-06-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN114644621B (zh) | 治疗新冠肺炎口服药物s-217622的制备方法 | |
US11365178B2 (en) | Method for preparing elagolix intermediate and composition thereof | |
JP3026020B2 (ja) | 3環性プテリジノン類及びその製造方法 | |
CN114751894A (zh) | 一种治疗新冠肺炎口服药物的制备方法 | |
JPS58180481A (ja) | 新規なピペリジン誘導体 | |
WO2007049798A1 (ja) | 新規ベンゾオキサチイン誘導体 | |
CN104418807A (zh) | 一种2-乙氧基-1-[[2`-(羟基脒基)-联苯基]-4-基]甲基-1h-苯并咪唑-7-羧酸及其酯衍生物的制备方法 | |
CN114853741B (zh) | 一种新冠病毒主蛋白酶抑制剂的制备方法 | |
CN105440034A (zh) | 一种利格列汀及其中间体的制备方法 | |
WO2010055133A1 (en) | Benzimidazole derivatives and their use for modulating the gabaa receptor complex | |
CA1117525A (en) | 2,3-polymethylene-4-oxo-4h-pyrido /1,2-a/ pyrimidines and process for the preparation thereof | |
CN111574520B (zh) | 一种利格列汀中间体化合物ⅴ | |
Sączewski et al. | Synthesis of 2, 3-dihydroimidazo [1, 2-a] pyrimidin-5 (1H)-ones by the domino Michael addition retro-ene reaction of 2-alkoxyiminoimidazolidines and acetylene carboxylates | |
CA2743537C (en) | Benzimidazole derivatives and their use for modulating the gabaa receptor complex | |
CN111574463A (zh) | 一种利格列汀中间体化合物ⅳ | |
US10562889B2 (en) | Process for the preparation of 1-(arylmethyl)quinazoline-2,4(1H,3H)-diones | |
Shuangxia et al. | An efficient and green synthetic route to losartan | |
US6184382B1 (en) | Process for preparing N6-substituted adenosine derivatives | |
CN115109041B (zh) | 一种3cl蛋白抑制剂恩赛特韦的合成方法及其中间体 | |
Hu et al. | Small change for big improvement in the preparation of the key intermediate N 1, N 3-disubstituted 1, 3, 5-triazone of ensitrelvir | |
CA2743531A1 (en) | Benzimidazole derivatives and their use for modulating the gabaa receptor complex | |
CN112979643B (zh) | 3-(2-氯乙基)-9-羟基-2-甲基-4H-吡啶并[1,2-a]嘧啶-4-酮 | |
EP2729463B1 (en) | Substituted phenyl compounds | |
JP5171649B2 (ja) | 選択的アンドローゲン受容体モジュレーターとして有用な、二環式イミダゾール又はチアジアゾール複素環 | |
JPS59170091A (ja) | 6−チオ−7−デアザプリン誘導体およびその製造法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information |
Inventor after: Xu Xuenong Inventor after: Zeng Deli Inventor after: Bao Zhijian Inventor after: Leng Xiuyun Inventor after: Su Jian Inventor after: Gu Xinyu Inventor before: Xu Xuenong Inventor before: Zeng Deli Inventor before: Bao Zhijian Inventor before: Leng Xiuyun Inventor before: Su Jian Inventor before: Gu Xinyu |
|
CB03 | Change of inventor or designer information | ||
GR01 | Patent grant | ||
GR01 | Patent grant |